We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Autolus Therapeutics PLC | NASDAQ:AUTL | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.32 | 8.70% | 4.00 | 3.91 | 4.21 | 4.165 | 3.625 | 3.68 | 7,722,913 | 00:26:44 |
|
|
|
|
|
|
|
Exhibit
No.
|
|
Description
|
|
|
|
|
Unaudited Condensed Consolidated Interim Financial Statements for the Three and Nine Months Ended September 30, 2019
|
|
|
|
|
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three and Nine Months Ended September 30, 2019
|
|
|
|
|
101
|
|
The following materials from this Report on Form 6-K are formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine Months ended September 30, 2019 and 2018 (Unaudited), (ii) Condensed Consolidated Balance Sheet as at September 30, 2019 and December 31, 2018 (Unaudited), (iii) Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Three and Nine Months ended September 30, 2019 and 2018 (Unaudited), (iv) Condensed Consolidated Statements of Cash Flows for the Nine Months ended September 30, 2019 and 2018 (Unaudited), and (v) Notes to Condensed Consolidated Financial Statements (Unaudited).
|
|
|
Autolus Therapeutics plc
|
||
|
|
|
|
|
Date:
|
November 7, 2019
|
By:
|
/s/ Christian Itin
|
|
|
|
|
Name
|
Christian Itin, Ph.D.
|
|
|
|
Title:
|
Chief Executive Officer
|
1 Year Autolus Therapeutics Chart |
1 Month Autolus Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions